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570Objective: Our objective was to establish baseline data and develop a tool to allow for systematic evaluation of
pediatric cardiac surgical complications. As a first step, we examined the incidence and distribution of compli-
cations, risk stratified by case complexity in a single institution. With improving mortality rates for congenital
heart surgery, the next frontier for improving patient outcomes is characterizing and reducing complications.
Currently, no standardized approach is available to monitor the incidence and severity of all complications as-
sociated with a congenital cardiac surgery program.
Methods: Complications occurring in pediatric cardiac surgical patients (January 2006 to March 2009) were
collected by database review applying standardized definitions. The surgical procedures were stratified by com-
plexity to analyze the distribution of complications over the risk spectrum. Each complication was assigned a se-
verity coefficient (1–3) used to calculate the combined effect of frequency and severity. The cumulative sum
method was used to determined the trend of the adverse outcomes.
Results: Of 292 procedures, 84 (28.8%) were associated with a total of 150 complications. Of the 150 compli-
cations, 37 occurred in patients who died. The most common complications were arrhythmias (14.5%), cardiac
(12.6%), and operative (12.6%). There was a linear relationship between the frequency and severity of compli-
cations and surgical complexity, as stratified using the Risk Adjustment for Congenital Heart Surgery category
or Aristotle basic complexity levels (Spearman’s coefficient ¼ 1).
Conclusions: When examined in a systematic fashion, the risk of complications in pediatric cardiac surgical
patients is considerable. Our data illustrate that it is possible to track complications over time in a consistent
manner. The effect of complication monitoring on patient outcomes remains to be proved. (J Thorac Cardiovasc
Surg 2012;144:570-6)Pediatric cardiac surgery is a discipline in evolution, with
progressively improving mortality rates. As public demand
for institutional reporting of outcomes has grown, the pro-
fession has searched for accurate and objective measures
of program performance. Mortality is a well-defined, uni-
versally captured, and readily measured outcome. The re-
porting and comparison of institutional outcomes, to date,
has focused on overall operative mortality, currently 4%
in large multi-institutional data sets.1 However, a large pro-
portion of adverse outcomes are attributable to nonfatal
complications that are not captured in mortality reports.
Morbidity is defined as ‘‘a state of illness or lack of health
that includes physical, mental or emotional disability’’ by
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The Journal of Thoracic and Cardiovascular SurgHeart Disease.2 Hence all operations are accompanied by
some degree of morbidity. A complication, however, is de-
fined as ‘‘an event or occurrence that is associated with dis-
ease or a healthcare intervention that is (a) a departure from
the desired course of events and (b) may cause or be associ-
ated with suboptimal outcome.’’2 Complications can nega-
tively affect patient outcomes, including length of stay in
the intensive care and hospital and long-term quality of
life.3 Complications can also be associated with an in-
creased cost to the healthcare system. Although in some re-
ports of adult cardiac surgery, complications are associated
with mortality,4 there is evidence to suggest that complica-
tions might reflect something different to mortality and
could beworth examining as a separate indicator of program
performance. For example, Silber and colleagues5 reported
that the hospital characteristics associated with mortality
were not associated with complications. Shroyer and associ-
ates6 also reported no significant correlation between risk-
adjusted mortality and risk-adjusted complications.
Although many centers collect and report series of
pathology-specific or case-specific complication data, no
systematic method of reporting the incidence or distribution
of complications for an entire surgical program is available.
Specifically, no benchmarks are in use for intra- orery c September 2012
Abbreviations and Acronyms
ABC ¼ Aristotle basic complexity
CUSUM ¼ cumulative sum
ECMO ¼ extracorporeal membrane oxygenation
RACHS ¼ Risk Adjustment for Congenital Heart
Surgery
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tions, even though up to 30% of congenital heart surgery
admissions can be associated with complications.7 An im-
portant step toward the meaningful collection of complica-
tion data was the Multi-Societal Committee for Pediatric
and Congenital Heart Disease definition list of surgical
complications.2
The objective of the present study was to report the
frequency of complications in a retrospective single-
institution pediatric cardiac surgical cohort using standard-
ized definitions. Our secondary objective was to develop
a complication reporting system to accurately capture pedi-
atric cardiac surgery complications and to examine the inci-
dence and distribution of complications, stratified by
surgical case complexity. Rather than trying to provide spe-
cific complication data for a given operation or diagnosis,
we have attempted to develop a tool that will allow pro-
grams to monitor their own outcomes in real time, to be
able to respond quickly to any changes in the incidence of
complications, and to thus enhance patient outcomes.
METHODS
The research ethics board of the IWK Health Centre approved the retro-
spective cohort analysis of complications occurring in congenital cardiac
surgical procedures from January 1, 2006, to March 31, 2009. The IWK
Health Centre is the tertiary referral center for Atlantic Canada and is
a full-service cardiac surgical center, with the exception of cardiac trans-
plantation and long-term ventricular assist device implantation. All cardiac
surgical procedures performed during the study period were included in the
analysis, with the exception of surgical closure of patent ductus arteriosus
in premature neonates, primary extracorporeal membrane oxygenation
(ECMO) and cardiac pacemaker and defibrillator implantations. Complica-
tions were collected by database review using the short list of 52 compli-
cations as defined by the Multi-Societal Committee for Pediatric and
Congenital Heart Disease.2 Complications were identified by 1 clinic nurse
on a quarterly basis by scanning each patient chart and identifying the com-
plications recorded in the progress notes and discharge summaries (com-
pleted contemporaneously with patient discharge by the attending
pediatric cardiologist and dictated by the attending pediatric cardiac sur-
geon). On a quarterly basis, the pediatric cardiologists and cardiac surgeons
met and reviewed each of the patients and all the complications. Any dis-
cussion regarding complication identification or reclassification led to ad-
ditional chart review and a final record of the complications was made. On
an annual basis, the entire cohort and all the complications were reviewed
numerically to inform the group of the overall program performance. Com-
plications that did not fit into the standardized definition list were included
under the heading ‘‘other complications.’’
The surgical procedures were risk stratified according to surgical com-
plexity using either the Risk Adjustment for Congenital Heart Surgery
(RACHS)8 or Aristotle basic complexity (ABC) scores.9 The RACHSThe Journal of Thoracic and Cacategory is an expert consensus ranking of 79 surgical procedures that
was developed as a risk-adjustment tool according to the differences in sur-
gical complexity and validated for comparing mortality outcomes. The
ABC score is determined by expert consensus of surgical complexity and
the likelihood of complications. The surgical complexity score was as-
signed according to the highest risk procedure in the event that an operation
involved 2 or more procedures performed concurrently.
Mortality was classified as intraoperative or postoperative, including all
deaths occurring within 30 days postoperatively or during the index hospi-
talization. To factor in the severity of complications to our model, each
complication was weighted by assigning a severity coefficient (range,
1–3), according to expert consensus, ranging from the lowest severity (se-
verity coefficient 1, defined as mild or temporary deficit, predicted to min-
imally affect the patient’s course and outcome) to the greatest severity
(severity coefficient 3, defined as a severe and/or permanent complication
predicted to significantly impair the patient’s outcome and possibly pre-
cede death). For calculations in which patients experiencing mortality
were included in the analysis, death was assigned a severity coefficient
of 5. Because of the debate surrounding the inclusion of ‘‘mortality’’ as
a complication, we included death as a category of complication for the first
part of the analysis and excluded cases with mortality for the second part of
the analysis. Complications categorized as ‘‘other’’ were not assigned a se-
verity coefficient.
To determine the total magnitude of complications (a variable we have
termed ‘‘morbidity burden’’) in a single surgical complexity stratum, the
weighted complications were stratified by RACHS category or ABC level
and then summed (morbidity burden¼ S [frequency3 severity]) for each
procedure in a particular category. RACHS categories 5 and 6 were col-
lapsed into a single category owing to the small number of procedures in
each category. Because of the unequal distribution of procedures across
the RACHS categories (Table 1), the morbidity burden was divided by
the number of procedures in the corresponding surgical stratum to generate
a variable we termed ‘‘indexed morbidity,’’ which is a reflection of the av-
erage morbidity burden per procedure in each risk category (indexed
morbidity ¼ morbidity burden/number of procedures in category).
The cumulative sum (CUSUM) method was applied to track adverse
outcomes over time. To construct a CUSUM plot, consecutive cases
were plotted as a single unit on the x axis and the occurrence of any adverse
event was plotted by the movement of 1 unit on the y axis. The construction
of alarm limits on the CUSUM curves is possible using the technique de-
scribed by Rogers and colleagues.10 The following values were used to
construct the alarm limits. First, using our retrospective data, the ‘‘accept-
able’’ morbidity rate was set at 28.8%. Second, the unacceptable morbidity
rate was set at 1.5 times the acceptable mortality rate (43.2%). Third, the
type 1 (a) error rate was set at 5%. Finally, the type 2 (b) error rate was set
at 5%.
Statistical Analysis
The raw frequency data were obtained for each complication. We com-
pared the incidence and severity of the complications separately in the sur-
vivors and deceased patients. A CUSUM plot was derived for the
complications of the entire cohort.RESULTS
Demographics
From January 1, 2006 to March 31, 2009, 268 patients
(median age, 178 days; range, 1 day to 18 years) underwent
292 procedures (Table 1). Of the 268 patients, 50 were ne-
onates (17.1%) and 132 were infants (45.9%). Most (205/
292) procedures were RACHS category 2 or 3. Procedures
performed 5 or more times accounted for 208 (71%) of the













morbidities (n) Mortality (n)
1 57 6 6 6 0 0
2 115 36 23 16 7 1
3 90 72 39 23 16 5
4 12 13 8 5 3 0
5 and 6 18 23 8 3 5 3
Total 292 150 84 53 31 9 (3.1)
Data in parentheses are percentages. RACHS, Risk Adjustment for Congenital Heart Surgery.
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The overall procedural mortality was 3.1% (9/292,
Figure 1).Mortality increased from 0% in RACHS category
1 to 16.7% (3/18) in RACHS category 5/6 (Table 1). Each of
the 3 deaths in RACHS categories 5/6 were patients under-
going Norwood procedures who developed severe cardiac
dysfunction after cardiotomy with the subsequent need for
ECMO, followed by sepsis and renal failure. Of the 150
complications, 37 (24.6%) occurred in the 9 patients who
eventually died. Also, 22 of the 150 complications were ma-
jor adverse cardiac events. Of these 22 major adverse car-
diac complications, 10 occurred in patients who died. In
the patients who died, the primary complications were car-
diac (severe cardiac dysfunction, low cardiac output, un-
planned cardiac reoperation, and ECMO), followed by
a series of secondary complications (eg, sepsis and renal
failure) that eventually culminated in death.Total Morbidity
Of the 292 procedures, 84 (28.8%) were associated
with a total of 150 complications (average, 0.5 complica-
tions/procedure; Table 1). Most procedures with compli-
cations (53/84) were associated with a single
complication. Multiple complications occurred in 31 pro-
cedures (Table 1). Most complications occurred in the
RACHS category 3 procedures. Arrhythmias and cardiac
and operative complications accounted for 39.7% of allFIGURE 1. Cumulative sum (CUSUM) plot of mortality in the entire co-
hort. Using 3.5% as an ‘‘acceptable’’ mortality rate, according to our insti-
tutions’ historic rates and published data rates of current mortality in
pediatric cardiac surgery cohorts, the slope of the curve remains between
the alarm limits for the entire duration of the study, implying that program
is ‘‘in control’’ with regard to mortality rates.
572 The Journal of Thoracic and Cardiovascular Surgcomplications (Figure 2). Eight procedures were associ-
ated with postcardiotomy ECMO. Of the 150 complica-
tions, 16 (10.7%) did not meet the Multi-Societal
Committee standardized definitions and were categorized
as ‘‘other.’’ Included in the ‘‘other’’ category were vascu-
lar or conduit thromboses (n ¼ 3), urinary tract infection
or intravenous site infection (n ¼ 3), gastrointestinal or
gastrourinary bleeding (n ¼ 2), hypertension (n ¼ 2), stri-
dor (n ¼ 2), aspiration (n ¼ 1), hepatic dysfunction
(n ¼ 1), intussusception (n ¼ 1), and a major skin com-
plication (n ¼ 1).Complications Stratified by Surgical Complexity and
Severity
A peak was found in the raw frequency of complications
and the morbidity burden in the mid-complexity cases
(RACHS 3 or ABC level 2 and 3; Figure 3, A and B).FIGURE 2. Total cohort complications stratified by the organ system.
Complications were grouped according to the Multi-Societal Committee
for Pediatric and Congenital Heart Disease classification. Most complica-
tions in our retrospective analysis were arrhythmias (14.5%) and cardiac
(12.6%) and operative (12.6%) complications. The 16 complications
(10.1%) classified as ‘‘other’’ included vascular or conduit thrombosis
(n¼ 3), urinary tract or intravenous site infections (n¼ 3), gastrointestinal
or genitourinary bleeding (n ¼ 2), hypertension associated with recoarcta-
tion (n¼ 2), stridor (n¼ 2), aspiration (n¼ 1), hepatic dysfunction (n¼ 1),
intussusception (n¼ 1), and a skin blister secondary to antiseptic skin prep-
aration solution (n ¼ 1).
ery c September 2012
FIGURE 3. Complications stratified by surgical complexity. The highest
complication frequency (white bars) and morbidity burden (black bars;
calculated by summing the product of complications multiplied by the se-
verity coefficient for a given surgical stratum) was in (A) Risk Adjustment
for Congenital Heart Surgery (RACHS) category 3 and (B) Aristotle basic
complexity (ABC) level 2. These were also the groups with the greatest
number of procedures.
FIGURE 4. Risk-stratified complications indexed to the number of proce-
dures in each surgical strata. There was a linear relationship between in-
dexed morbidity (y axis; calculated as S[complication frequency 3
severity coefficient]/number of procedures per surgical strata) and com-
plexity of the procedure (x axis) according to (A) Risk Adjustment for
Congenital Heart Surgery (RACHS) category or (B) Aristotle basic com-
plexity (ABC) level.
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burden indexed to the number of procedures in that stratum
of surgical complexity (Figure 4, A and B). When we an-
alyzed the complications by specific procedure, rather
than by RACHS category, a similar linear relationship
was found between the indexed morbidity and the com-
plexity of the procedure (data not shown). We then ana-
lyzed complications by severity versus surgical
complexity. The frequency of severity 3 complications in-
creased from 1.7% in RACHS category 1 to 61.1% in
RACHS category 6. The frequency of severity 2 complica-
tions demonstrated a similar pattern (RACHS 1, 0%;
RACHS 6, 66.7%). Severity 1 complications, however, oc-
curred at a rate of 5.2% and 6.1% in RACHS 1and 2, re-
spectively, but were absent in RACHS categories 4, 5, and
6 (data not shown).
Survivors Versus Nonsurvivors
To explore the relationship between complications and
death, we divided the total cohort into survivors (n ¼ 283)
and nonsurvivors (n ¼ 9). Regardless of the RACHS cate-
gory, the average indexed morbidity of the nonsurvivors
was greater (10.0 1.0; range, 9–11) than that of the survi-
vors (1.07  0.61; range, 0.4–1.6). The frequency of sever-
ity 1 complications in nonsurvivors was threefold that of the
survivors. Likewise severity 2 complications occurred 9
times more frequently and severity 3 complications 22The Journal of Thoracic and Catimes more frequently in the nonsurvivors than in the survi-
vors (data not shown).CUSUM Plots of Morbidity
We applied the CUSUM method to the analysis of com-
plications in the total cohort (Figure 5, A). The slope of the
line was less than that of the control limits such that the
lower alarm limit was crossed at patients 90 to 92. This im-
plies that the complications were accrued at a slower rate
than predicted or that the program was outperforming the
model after the first third of the series.
To account for the frequency and severity of complica-
tions associated with each procedure, we calculated the
morbidity burden associated with every procedure in the se-
ries and plotted the morbidity burden against the sequential
case number (Figure 5, B). The morbidity burden curve (up-
per curve) demonstrated a much greater slope than the curve
that simply plots the number of procedures with any com-
plication (lowest curve). When nonsurvivors were excluded
from this analysis, a notable decrease was found in the slope
of the curve (middle curve vs upper curve), demonstrating
the effect of death on the morbidity burden. The morbidity
burden across the entire cohort of 292 procedures was 337
(indexed morbidity, 1.15). The morbidity burden in the
283 survivors was 211 (indexed morbidity, 0.74).rdiovascular Surgery c Volume 144, Number 3 573
FIGURE 5. Cumulative sum (CUSUM) plot of complications in the total
cohort. A, Plotting the occurrence of any complication versus procedure
number generates a plot of overall program performance but does not incor-
porate the concept of frequency and severity into the graphic depiction of
outcome. B, Three curves showing the dramatic effect on the slope of the
linewhen one incorporates frequency and severity (morbidity burden in en-
tire cohort) into the reporting of complications (upper curve) compared
with simply plotting the occurrence of any complication (morbidity, lowest
curve). It also illustrates the effect of including deaths in the analysis (upper
curve) compared with excluding deaths from the analysis (morbidity bur-
den in survivors, middle curve).
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Historically, operative mortality has been the primary
tool for judging performance in congenital cardiac surgery.
In the current era, overall congenital cardiac surgical mor-
tality has been reported as 4%.1We have shown, in the pres-
ent report, that complications occur at a greater frequency in
patients dying but also at reasonably high rates in those not
dying as an endpoint. As a result of the distribution of com-
plications, most patient outcomes were unaccounted for
when using mortality as the sole indicator of performance
in a pediatric cardiac surgical program.
In contrast to mortality, the capture and reporting of com-
plications is relatively difficult. Because of the complexity
of defining and accurately reporting complications, there
has been some effort to identify surrogate markers of com-
plications. O’Brien and colleagues11 chose a prolonged hos-
pital stay (>21 days) as a marker of morbidity, and Clarke
and associates12 proposed using postoperative length of574 The Journal of Thoracic and Cardiovascular Surgstay and ventilator duration. Both the length of hospital
stay and the ventilation duration have not been validated
as surrogates for morbidity. For example, a stay in the hos-
pital of longer than 21 days for a neonate does not necessar-
ily imply the occurrence of a complication because the
duration of the preoperative phase is variable, depending
on the pathologic features and comorbidities in a given pa-
tient. Likewise, postoperative stays are often prolonged for
reasons other than operative complications, including feed-
ing, growth, and social issues. The development of a com-
prehensive list of specific, rather than surrogate, markers
has allowed, for the first time, the collection of detailed
complication data for patients and cohorts program-wide.
Whether to include mortality in the computation of com-
plications has been debated in published reports.12 We in-
cluded mortality in our results because we can imagine
a scenario in which a surgical program could have low or
acceptable complication rates, as a result of having high
mortality rates. This apparent contradiction in program per-
formance, depending on whether mortality or morbidity is
studied, can be prevented by including deaths in the calcu-
lation of the complications. By weighting death with a large
severity coefficient, the effect of mortality can be empha-
sized in a series of complications. We arbitrarily used a se-
verity coefficient of 5 for death, although that might be too
small a number to accurately represent the full magnitude of
the outcome.
One third of all procedures were associated with compli-
cations, a rate consistent with other published reports.7
Most of the complications occurred in patients in RACHS
category 3 (ABC level 2) and greater. However, merely doc-
umenting the occurrence or frequency of complication oc-
currence does not convey the effect of complications on
an individual patient or a patient cohort. For example,
5 wound infections in any particular surgical complexity
stratum are likely to have a very different net effect on the
patient population than 5 ECMO occurrences in the same
patient group. Likewise, the effect of stroke or renal failure
on overall outcome and quality of life clearly differs from
the effect of a superficial wound infection. Thus, along
with frequency of occurrence, there must be some way to
factor severity into the reporting of complications. We in-
corporated complication severity into our system by assign-
ing a severity coefficient (range, 1–3) based on the expert
consensus of how likely (or not) a particular complication
is to predate death (with death assigned a severity coeffi-
cient of 5). Although there can be debate about what actual
number should be assigned as a coefficient, with large
enough data sets, these coefficients will be generated by
the data themselves.
To risk stratify complications, which has not been under-
taken in published studies before our report, surgical com-
plexity was invoked. The morbidity burden in each
surgical complexity stratum was calculated by summingery c September 2012
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its severity coefficient. The frequency and severity of com-
plications, when indexed to the number of procedures in
each group, correlated linearly with increasing surgical
complexity. It is intuitive that more complex procedures
would be associated with greater rates of complications,
but this has not been reported before the present study.
When the total population was divided into survivors and
nonsurvivors, the odds of developing a complication of any
severity was much greater in the nonsurvivors.When a com-
parative analysis between survivors and nonsurvivors was
performed, only the complications (excluding death) were
reported for each patient. A similar indexed morbidity
was associated with death, regardless of the surgical com-
plexity, implying that a similar amount of injury had to be
accrued before a patient died, regardless of the complexity
of the patient’s underlying pathologic features.
CUSUM Method to Report Adverse Outcomes
The CUSUM method is a simple, graphic display of per-
formance that was first used in quality assurance in indus-
trial manufacturing and has since applied to the analysis
of adverse occurrences in medicine.13 The slope of the
line on a CUSUM plot reflects the occurrence of adverse
events; the greater the slope of the line, the more frequent
the occurrence of adverse events.14 In 1994, de Leval and
colleagues15 presented a CUSUM analysis of mortality in
a surgical series of arterial switches. Since then, studies
have shown that CUSUM plots are more sensitive than stan-
dard statistical tests (eg, chi-square test) in identifying
a cluster of failures.16 Although CUSUM charts are simple
to construct, care is needed to avoid overinterpreting or mis-
interpreting them.10 Also, although CUSUM plots provide
a method of displaying data, they are not tests of statistical
significance; however, not all instances of deteriorating per-
formance need statistical proof to merit attention. When the
CUSUM curve reaches either the upper or lower alarm
limit, the process is said to be ‘‘out of control’’; however,
the CUSUM method does not have the discriminatory abil-
ity to identify systems that are destabilizing or ‘‘going out of
control.’’ With a CUSUM analysis, there is a tradeoff in the
choice of control limit. A broad limit provides protection
against false signals resulting from chance but will be
slow to detect a change in process performance, and a nar-
row control limit will detect changes quickly but will pro-
vide frequent false signals. In contrast to mortality, there
is a lack of objective comparator data with regard to
complications, making it difficult to set control limits on
a morbidity CUSUM curve. The CUSUM method has con-
ventionally been used to track mortality. We extended the
use of the CUSUMmethod to the analysis of complications.
Because this curve reflects each procedure that is associated
with at least 1 complication, it is not currently designed to
show the number of complications associated with eachThe Journal of Thoracic and Caprocedure or the severity of those complications. CUSUM
analysis of the morbidity burden for each procedure (the
sum of the severity coefficients for each complication asso-
ciated with that procedure), in addition to the number of
procedures with a complication, addresses this issue and ac-
counts for both the frequency and the severity of every com-
plication associated with each procedure and gives us
a better estimate of the effect of the complications associ-
ated with each procedure. Furthermore, it is possible to
track complications in the total cohort, as well as in survi-
vors, allowing us to estimate the effect of death on the mor-
bidity burden.
The concept of morbidity burden, coupled with the versa-
tility of the CUSUMmethod, has enabled us to develop a re-
porting system that not only estimates and tracks the burden
of complications in a given patient cohort but also tackles the
confounding effect of death on the complications. As with
surgicalmortality, the relationship of complications to surgi-
cal volume remains uncertain and, given the small numbers
of cases used to generate the present retrospective data,
using the absolutemorbidity datawehave reported is not nec-
essarily representative for comparison with other programs.
The CUSUM plots should ideally be risk adjusted to ac-
count for variations in preoperative risk to ‘‘level the play-
ing field.’’ We used the CUSUM method in the context of
pediatric cardiac surgery to track total complications and
complications stratified by severity. CUSUM plots could
also be used to track complications by specific procedure
(eg, Norwood procedure), specific complication (eg, ar-
rhythmia), or specific RACHS category. This is a method
in evolution and will undergo additional refinement as
more objective data become available.
Study Limitations
The retrospective design of the study resulted in inherent
limitations. Retrospective data capture could be associated
with an underreporting of complication frequency. The
small numbers of procedures in some groups hampered sub-
set analysis. Specifically, our small volume prevented any
meaningful calculation of disease-specific or operation-
specific complication rates. Furthermore, data from the
present retrospective single small-volume center should
not be overinterpreted and might not be representative for
comparison with other programs. As with surgical mortal-
ity, the relationship of complications to surgical volume re-
mains uncertain.
The absence of existing published data or benchmarks for
program-wide complications means that we can only com-
pare our results with our own historic data until such time as
other institutional data becomes available. This circular ref-
erence could be misleading, in that staying within alarm
limits only reflects current outcomes; thus, if these out-
comes are poor to start with, staying within the alarm limits
would be falsely reassuring. Once multicenter prospectiverdiovascular Surgery c Volume 144, Number 3 575
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and our data can be benchmarked against more objective
comparators. Our reporting only included pediatric cardiac
surgical procedures and not adult patients with congenital
heart disease.
CONCLUSIONS
When examined in a systematic fashion, the risk of com-
plications in pediatric cardiac surgical patients is consider-
able. Our data illustrate that it is possible to track
complications over time in a consistent manner. The effect
of complication monitoring on patient outcomes remains to
be proved.
The authors gratefully acknowledge Daniel Belliveau and
Trudy Hennigar for their assistance and Karen Buth for her statis-
tical consultation.
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